CancerVax
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
351 Paseo Nuevo Pmb 2, Santa Barbara, Ca...Phone Number
(805) 356-1810Website
www.cancervax.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About CancerVax
CancerVax is a pre-clinical biotech company focused on developing a revolutionary Universal Cancer Treatment Platform that utilizes the body's immune system to target and kill cancer cells by disguising them as common diseases like measles. Their innovative approach aims to simplify cancer treatment to a single injection, addressing the significant challenge of cancer cell recognition by the immune system. The company collaborates with leading experts and partners in biotechnology to enhance its therapeutic offerings. CancerVax targets a wide range of clients, including pharmaceutical and biotech companies, as well as research organizations involved in cancer treatment and immunotherapy.Explore more
CancerVax Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CancerVax your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if CancerVax had a recent Job posting/layoffs
Funding: Get notified immidiatlly once CancerVax has new funding data
Website visits: Recent activity has been detected on your website
CancerVax, which may be a good buyer, showed buying intent in Masked Content Topic
Check if CancerVax has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at CancerVax
Product Launch: Get notified when CancerVax launches new products
Check out if CancerVax is spiking on competitors!
Earning: See what the market has to say on CancerVax recently announced quarterly report
Recommended Actions
Find VP level buyers at CancerVax
Find 3 more new buyers
Compare Similar Companies to CancerVax
Compare insights from companies similar to CancerVax, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CancerVax is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
CancerVax is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about CancerVax.
CancerVax financials insights
Gather financial insights about CancerVax, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Other Financing Round
$10M
CancerVax Tech Stack
A closer look at the technologies used by CancerVax
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Funding
New Hire
Executive Move
New Hire
Executive Move
CancerVax News & Media
CancerVax Named a Top Preclinical Biotech Company of 2026 by Life Sciences Review
Independent industry recognition highlights the Company’s revolutionary immunotherapy platform and growing momentum in precision cancer treatment Independent industry recognition highlights the Company’s revolutionary immunotherapy platform and growing momentum in precision cancer treatmentCancerVax Develops Novel Smart mRNA to Harness Pre-Existing Immunity in 99% of World Population
Company completes design and in-vitro validation of a single Smart mRNA that disguises cancer as multiple viral infections simultaneously to activate pre-existing T-cell immunity Company completes design and in-vitro validation of a single Smart mRNA that disguises cancer as multiple viral infections simultaneously to activate pre-existing T-cell immunityCancerVax Successfully Demonstrates Full Nanoparticle Delivery in Mouse Study
First biodistribution study of the Company’s complete cancer targeting nanoparticle avoided many healthy organs First biodistribution study of the Company’s complete cancer targeting nanoparticle avoided many healthy organsCancerVax to Target Colorectal Cancer Following Recent Biodistribution Breakthroughs
New findings support hypothesis that current nanoparticle designed for pancreatic and liver cancers could also work for colorectal cancer New findings support hypothesis that current nanoparticle designed for pancreatic and liver cancers could also work for colorectal cancer
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding CancerVax
Sign Up For FreeTo access detailed company insights
CancerVax is a pre-clinical biotech company focused on developing a revolutionary Universal Cancer Treatment Platform that utilizes the body's immune system to target and kill cancer cells by disguising them as common diseases like measles. Their innovative approach aims to simplify cancer treatment to a single injection, addressing the significant... Read More
